U.S., May 8 -- ClinicalTrials.gov registry received information related to the study (NCT07573735) titled 'Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Dermatitis' on April 30.
Brief Summary: Study Overview Atopic dermatitis (AD), commonly known as eczema, is a chronic inflammatory skin condition characterized by intense itching and skin barrier damage. While researchers know that the immune system is overactive in AD, it is difficult to measure the exact level of "damage" or "inflammation" happening deep within the skin using only a physical exam.
The Purpose of This Study This study investigates a specific "danger signal" called circulating cell-free DNA (cfDNA). When skin cells are damaged or die due to i...